prostate cancer
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients with high serum PSA (2.8 ng/ml or more, and 50 ng/ml or less). Prostate cancer suspected patients with the mass in the prostate by rectal examination. Patients with localized prostate cancer suspected by MRI.
Exclusion criteria
Exclusion criteria: Patients whose diagnosis of prostate cancer does not contribute to the patient's life prognosis. Patients with serum PSA>50 ng/ml and suspected of progressive prostate cancer. Patients with suspected progressive prostate cancer by rectal examination. Patients with suspected progressive prostate cancer by MRI. Patients with abnormal coagulation Patients who are allergic to anesthetics and can not suffer from spinal subarachnoid anesthesia or sacral anesthesia. Patients judged inappropriate in this study by the doctor.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Histopathological findings of biopsy tissue. Analysis of difference between histopathological findings with image findings and specimens from total prostatectomy. | — |
Countries
Japan
Contacts
Hirosaki University school of medicine and hospital urology